Skip to main content
Login | Suomeksi | På svenska | In English

Comparing the performance of the gene prioritization methods DEPICT and MAGMA on genome-wide association studies of schizophrenia using the Benchmarker framework

Show simple item record

dc.date.accessioned 2020-05-06T08:38:52Z
dc.date.available 2020-05-06T08:38:52Z
dc.date.issued 2020-05-06
dc.identifier.uri http://hdl.handle.net/123456789/28250
dc.title Comparing the performance of the gene prioritization methods DEPICT and MAGMA on genome-wide association studies of schizophrenia using the Benchmarker framework en
ethesis.discipline none und
ethesis.department none und
ethesis.faculty Matemaattis-luonnontieteellinen tiedekunta fi
ethesis.faculty Faculty of Science en
ethesis.faculty Matematisk-naturvetenskapliga fakulteten sv
ethesis.faculty.URI http://data.hulib.helsinki.fi/id/8d59209f-6614-4edd-9744-1ebdaf1d13ca
ethesis.university.URI http://data.hulib.helsinki.fi/id/50ae46d8-7ba9-4821-877c-c994c78b0d97
ethesis.university Helsingin yliopisto fi
ethesis.university University of Helsinki en
ethesis.university Helsingfors universitet sv
dct.creator Ottensmann, Linda
dct.issued 2020
dct.language.ISO639-2 eng
dct.abstract It is challenging to identify causal genes and pathways explaining the associations with diseases and traits found by genome-wide association studies (GWASs). To solve this problem, a variety of methods that prioritize genes based on the variants identified by GWASs have been developed. In this thesis, the methods Data-driven Expression Prioritized Integration for Complex Traits (DEPICT) and Multi-marker Analysis of GenoMic Annotation (MAGMA) are used to prioritize causal genes based on the most recently published publicly available schizophrenia GWAS summary statistics. The two methods are compared using the Benchmarker framework, which allows an unbiased comparison of gene prioritization methods. The study has four aims. Firstly, to explain what are the differences between the gene prioritization methods DEPICT and MAGMA and how the two methods work. Secondly, to explain how the Benchmarker framework can be used to compare gene prioritization methods in an unbiased way. Thirdly, to compare the performance of DEPICT and MAGMA in prioritizing genes based on the latest schizophrenia summary statistics from 2018 using the Benchmarker framework. Lastly, to compare the performance of DEPICT and MAGMA on a schizophrenia GWAS with a smaller sample size by using Benchmarker. Firstly, the published results of the Benchmarker analyses using schizophrenia GWAS from 2014 were replicated to make sure that the framework is run correctly. The results were very similar and both the original and the replicated results show that DEPICT and MAGMA do not perform significantly differently. Furthermore, they show that the intersection of genes prioritized by DEPICT and MAGMA outperforms the outersection, which is defined as genes prioritized by only one of these methods. Secondly, Benchmarker was used to compare the performance of DEPICT and MAGMA on prioritizing genes using the schizophrenia GWAS from 2018. The results of the Benchmarker analyses suggest that DEPICT and MAGMA perform similarly with the GWAS from 2018 compared to the GWAS from 2014. Furthermore, an earlier schizophrenia GWAS from 2011 was used to check if the performance of DEPICT and MAGMA differs when a GWAS with lower statistical power is used. The results of the Benchmarker analyses make clear that MAGMA performs better than DEPICT in prioritizing genes using this smaller data set. Furthermore, for the schizophrenia GWAS from 2011 the outersection of genes prioritized by DEPICT and MAGMA outperforms the intersection. To conclude, the Benchmarker framework is a useful tool for comparing gene prioritization methods in an unbiased way. For the most recently published schizophrenia GWAS from 2018 there is no significant difference between the performance of DEPICT and MAGMA in prioritizing genes according to Benchmarker. For the smaller schizophrenia GWAS from 2011, however, MAGMA outperformed DEPICT. en
dct.subject Genome-wide association study
dct.subject Schizophrenia
dct.subject Cross-validation
dct.subject Linkage disequilibrium
dct.subject Heritability
dct.language en
ethesis.isPublicationLicenseAccepted true
ethesis.language.URI http://data.hulib.helsinki.fi/id/languages/eng
ethesis.language English en
ethesis.language englanti fi
ethesis.language engelska sv
ethesis.thesistype pro gradu -tutkielmat fi
ethesis.thesistype master's thesis en
ethesis.thesistype pro gradu-avhandlingar sv
ethesis.thesistype.URI http://data.hulib.helsinki.fi/id/thesistypes/mastersthesis
dct.identifier.ethesis E-thesisID:67bbb54c-5ece-449f-823c-92c5fd5144cf
dct.identifier.urn URN:NBN:fi:hulib-202005062017
dc.type.dcmitype Text
ethesis.facultystudyline Biostatistics and Bioinformatics fi
ethesis.facultystudyline Biostatistics and Bioinformatics en
ethesis.facultystudyline Biostatistics and Bioinformatics sv
ethesis.facultystudyline.URI http://data.hulib.helsinki.fi/id/SH50_134
ethesis.mastersdegreeprogram Life Science Informatics -maisteriohjelma fi
ethesis.mastersdegreeprogram Master's Programme in Life Science Informatics en
ethesis.mastersdegreeprogram Magisterprogrammet i Life Science Informatics sv
ethesis.mastersdegreeprogram.URI http://data.hulib.helsinki.fi/id/MH50_002

Files in this item

Files Size Format View
MT_ottensma.pdf 2.533Mb PDF

This item appears in the following Collection(s)

Show simple item record